Led by gains in Divi’s Labs, Sun Pharma, Cadila Healthcare, and Dr Reddy’s Laboratories, the Nifty Pharma pack was trading marginally higher in Wednesday’s trade, with most stocks hovering near their all-time high levels.

• L&T Shares Trade With Nominal Losses Despite Securing Orders 
• Daily vs Weekly SIP: Which Can Supercharge Your Portfolio to the Million-Mark?
• Rail Vikas Nigam Shares Take a Hit Despite Rs 165 Crore Order 
• Lupin Shares Gain 1% as Unit Receives EIR Status from USFDA
• Glenmark Unit Signs Exclusive NSCLC Drug Pact with Hansoh Pharma; Shares Drop 1%

Shares of Cipla hit a new all-time high of Rs 997 in Wednesday’s session, looking poised to enter the four digit-share club after the Drugs Controller General of India (DCGI) permitted the firm to import Moderna’s Covid Vaccine with emergency use authorization in India.

Stock Covered in the news

Sun Pharma-Ltd View Detailed Analysis

Cadila Healthcare-View Detailed Analysis